Epigenetic inactivation of the HOXA gene cluster in breast cancer

Cancer Research

Volumn 66, Issue 22, 2006, Pages 10664-10670

  Novak, Petr ^a,e   Jensen, Taylor ^a,b   Oshiro, Marc M ^a   Wozniak, Ryan J ^a,b   Nouzova, Marcella ^a   Watts, George S ^a   Klimecki, Walter T ^b,c   Kim, Christina ^a,d   Futscher, Bernard W ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e INSTITUTE OF PLANT MOLECULAR BIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE;

ARTICLE; BREAST CANCER; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE CLUSTER; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; HOX GENE; HOXA GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 33845319262     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2761     Document Type: Article

References (20)

1. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
2. Zardo G, Tiirikainen MI, Hong C, et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat Genet 2002;32:453-8.
3. Frigola J, Song J, Stirzaker C, et al. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 2006;38:540-9.
4. Ringrose L, Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 2004;38:413-43.
5. Oshiro MM, Watts GS, Wozniak RJ, et al. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene 2003;22:3624-34.
6. Oshiro MM, Kim CJ, Wozniak RJ, et al. Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Res 2005;7:R669-80.
7. Clark SJ, Harrison J, Paul CL, et al. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994;22:2990-7.
8. Cross SH, Charlton JA, Nan X, et al. Purification of CpG islands using a methylated DNA binding column. Nat Genet 1994;6:236-44.
9. Nouzova M, Holtan N, Oshiro MM, et al. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays. J Pharmacol Exp Ther 2004;311:968-81.
10. Weber M, Davies JJ, Wittig D, et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005;37:853-62.
11. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
12. Wu Z, Irizarry RA. Preprocessing of oligonucleotide array data. Nat Biotechnol 2004;22:656-8; author reply 658.
13. Huang TH, Perry MR, Laux DE. Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 1999;8:459-70.
14. Narayan A, Ji W, Zhang XY, et al. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. Int J Cancer 1998;77:833-8.
15. Costello JF, Fruhwald MC, Smiraglia DJ, et al. Aberrant CpG-isIand methylation has non-random and tumour-type-specific patterns. Nat Genet 2000;24:132-8.
16. Engelman JA, Zhang XL, Lisanti MP. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1): methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Lett 1999;448:221-30.
17. Reynolds PA, Sigaroudinia M, Zardo G, et al. Tumor suppressor P16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J Biol Chem 2006;281:24790-802.
18. Raman V, Martensen SA, Reisman D, et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000;405:974-8.
19. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980;20:85-93.
20. Cameron EE, Bachman KE, Myohanen S, et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-7.